Cyclophilin A interacts with diverse lentiviral capsids

Retrovirology

Volumn 3, Issue , 2006, Pages

  Lin, Tsai Yu ^a   Emerman, Michael ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN A; PROLINE;

ARTICLE; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MOLECULAR EVOLUTION; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN INTERACTION; RETROVIRUS INFECTION; SEQUENCE HOMOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS CAPSID; VIRUS MUTATION; VIRUS STRAIN;

ANIMALS; CAPSID; CAPSID PROTEINS; CATS; CELL LINE; CYCLOPHILIN A; HIV-1; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; JURKAT CELLS; LENTIVIRUS INFECTIONS; MUTAGENESIS; SIMIAN IMMUNODEFICIENCY VIRUS;

FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MIRIDAE;

EID: 33750390377     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-3-70     Document Type: Article

References (38)

1. Luban J, Bossolt KL, Franke EK, Kalpana GV, Goff SP: Human immunodeficiency virus type I Gag protein binds to cyclophilins A and B. Cell 1993, 73(6):1067-1078.
2. Franke EK, Yuan HE, Luban J: Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994, 372(6504):359-362.
3. Thali M, Bukovsky A, Kondo E, Rosenwirth B, Walsh CT, Sodroski J, Gottlinger HG: Functional association of cyclophilin A with HIV-1 virions. Nature 1994, 372(6504):363-365.
4. Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, Sundquist WI, Hill CP: Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 1996, 87(7):1285-1294.
5. Braaten D, Franke EK, Luban J: Cyclophilin A is required for the replication of group M human immunodeficiency virus type I (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses. J Virol 1996, 70(7):4220-4227.
6. Bukovsky AA, Weimann A, Accola MA, Gottlinger HG: Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence. Proc Natl Acad Sci U S A 1997, 94(20):10943-10948.
7. Franke EK, Luban J: Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 1996, 222(1):279-282.
8. Sokolskaja E, Sayah DM, Luban J: Target cell cyclophilin A modulates human immunodeficiency virus type I infectivity. J Virol 2004, 78(23):12800-12808.
9. Hatziioannou T, Perez-Caballero D, Cowan S, Bieniasz PD: Cyclophilin interactions with incoming human immunodeficiency virus type I capsids with opposing effects on infectivity in human cells. J Virol 2005, 79(1):176-183.
10. Kootstra NA, Munk C, Tonnu N, Landau NP, Verma IM: Abrogation of postentry restriction of HIV-I-based lentiviral vector transduction in simian cells. Proc Natl Acad Sci U S A 2003, 100(3):1298-1303.
11. Towers GJ, Hatziioannou T, Cowan S, Goff SP, Luban J, Bieniasz PD: Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med 2003, 9(9):1138-1143.
12. Towers GJ: Control of viral infectivity by tripartite motif proteins. Hum Gene Ther 2005, 16(10):1125-1132.
13. Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, Diaz-Griffero F, Anderson DJ, Sundquist WI, Sodroski J: Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A 2006, 103(14):5514-5519.
14. Wu XL, Anderson JL, Campbell EM, Joseph AM, Hops TJ: Proteasome inhibitors uncouple rhesus TRIM5 alpha restriction of HIV-1 reverse transcription and infection. Proc Natl Acad Sci U S A 2006, 103(19):7465-7470.
15. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J: The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427(6977):848-853.
16. Goff SP: Retrovirus restriction factors. Mol Cell 2004, 16(6):849-859.
17. Sayah DM, Sokolskaja E, Berthoux L, Luban J: Cyclophilin A retro-transposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430(6999):569-573.
18. Nisole S, Lynch C, Stoye JP, Yap MW: A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc Natl Acad Sci U S A 2004, 101(36):13324-13328.
19. Berthoux L, Sebastian S, Sokolskaja E, Luban J: Cyclophilin A is required for TRIM5(alpha)-mediated resistance to HIV-1 in Old World monkey cells. Proc Natl Acad Sci U S A 2005, 102(41):14849-14853.
20. Stremlau M, Song B, Javanbakht H, Perron M, Sodroski J: Cyclophilin A: An auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1. Virology 2006, 351(1):112-120.
21. Diaz-Griffero F, Vandegraaff N, Li Y, McGee-Estrada K, Stremlau M, Welikala S, Si Z, Engelman A, Sodroski J: Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. Virology 2006.
22. Zhang F, Hatziioannou T, Perez-Caballero D, Derse D, Bieniasz PD: Antiretroviral potential of human tripartite motif-5 and related proteins. Virology 2006, 353(2):396-409.
23. Saenz DT, Teo W, Olsen JC, Poeschla EM: Restriction of feline immunodeficiency virus by Refl Lv1, and primate TRIM5alpha proteins. J Virol 2005, 79(24):15175-15188.
24. Mortola E, Endo Y, Ohno K, Watari T, Tsujimoto H, Hasegawa A: The use of two immunosuppressive drugs, cyclosporin A and tacrolimus, to inhibit virus replication and apoptosis in cells infected with feline immunodeficiency virus. Vet Res Commun 1998, 22(8):553-563.
25. Meers J, del Fierro GM, Cope RB, Park HS, Greene WK, Robinson WF: Feline immunodeficiency virus infection: plasma, but not peripheral blood mononuclear cell virus titer is influenced by zidovudine and cyclosporine. Arch Virol 1993, 132(1-2):67-81.
26. Keckesova Z, Ylinen LM, Towers GJ: Cyclophillin A renders human immunodeficiency virus type I sensitive to Old World monkey but not human TRIM5 alpha antiviral activity. J Virol 2006, 80(10):4683-4690.
27. Sokolskaja E, Berthoux L, Luban J: Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type-I infectivity in human cells. J Virol 2006, 80(6):2855-2862.
28. Keckesova Z, Ylinen LM, Towers GJ: The human and African green monkey TRIM5alpha genes encode Refl and Lvl retroviral restriction factor activities. Proc Natl Acad Sci U S A 2004, 101(29):10780-10785.
29. Sawyer SL, Wu LI, Emerman M, Malik HS: Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci U S A 2005, 102(8):2832-2837.
30. Yamashita M, Emerman M: Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J Virol 2004, 78(11):5670-5678.
31. Loewen N, Barraza R, Whitwam T, Saenz DT, Kemier I, Poeschla EM: FIV Vectors. Methods Mol Biol 2003, 229:251-271.
32. O'Doherty U, Swiggard WJ, Malim MH: Human immunodeficiency virus type I spinoculation enhances infection through virus binding. J Virol 2000, 74(21):10074-10080.
33. Sebastian S, Luban J: TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2005, 2:40.
34. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, Thompson JD: Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Research 2003, 31(13):3497-3500.
35. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG: The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Research 1997, 25(24):4876-4882.
36. Schwede T, Kopp J, Guex N, Peitsch MC: SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Research 2003, 31(13):3381-3385.
37. Guex N, Peitsch MC: SWISS-MODEL and the Swiss-Pdb-Viewer: An environment for comparative protein modelling. Electrophoresis 1997, 18:2714-2723.
38. Peitsch MC: Protein modeling by E-mail. Bio/Technotogy 1995, 13:658-660.